Detalhe da pesquisa
1.
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.
J Am Acad Dermatol
; 80(4): 913-921.e9, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29410014
2.
TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde-Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology.
Clin Pharmacol Ther
; 114(5): 1093-1103, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562824
3.
The fate of 4-hydroxycarbazole metabolite: metabolism and carcinogenicity assessment of a ß-adrenergic receptor modulator containing carbazole structure.
Xenobiotica
; 41(12): 1108-21, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21892880
4.
Characterization of dark liver pigment observed in rats after subchronic dosing of the beta3-adrenergic receptor agonist LY368842.
Chem Res Toxicol
; 16(7): 912-9, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12870894